Company intelligence / Profile preview

BioFactura

Frederick, Maryland, United Statesbiofactura.com ↗
Ownership
Private
Employees
~50
Development stage
Phase 1
01

Overview

BioFactura has developed a pipeline of high-value biosimilars, biodefense medical countermeasures—including a lead smallpox therapeutic with significant BARDA funding—and first-in-class novel drugs. The company leverages its proprietary StableFast™ platform to enable rapid, cost-effective production of these products. Clinical progress includes advanced development contracts for its smallpox drug; other programs span from preclinical to clinical trial material manufacturing.[1][3][4][5]

Therapeutic areas
Infectious Diseases
Modalities
Biosimilars (generic biologics)Monoclonal antibodies (mAbs)Novel biologics/therapeutic proteins (Note: The company focuses on biosimilars and novel drugs, including therapeutic proteins and antibodies[1][3][4].)
Industry
Biotech
02

Drug pipeline

2 assets

ustekinumab biosimilar BFI-751

1

1 more asset in the full pipeline.

Request access →
03

Partnerships

Biomedical Advanced Research and Development Authority (BARDA)[5]Frederick Innovative Technology Center/FITCI incubator support[5]

Beyond the preview

Go deeper on BioFactura.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioFactura.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call